SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...Backers Continue to Bet Big Money on Promising Biotechs
Biotechnology/Health Care ColumnI’ll lead this week off with a couple of large financing rounds that have entered the fray in San Diego’s biotech sphere: February 28, 2014 10:11 a.m. $$ ShareTandem Diabetes Reports Sales Boosts for Q4, 2013
Tandem Diabetes Care Inc. reported sales of $29 million for the year ended Dec. 31, 2013, compared with $2.5 million for 2012.
Scripps Health Breaks Ground on $175M Medical Office Building
Scripps Health broke ground on its new, $175 million medical office building at Scripps Memorial Hospital La Jolla – part of a $2 billion renovation plan for the campus.
Sequenom Announces Leadership Changes, New CEO
Genetic testing company Sequenom Inc. is shaking up its leadership with a number of internal promotions.
Acadia Prices Public Offering of Common Stock
Acadia Pharmaceuticals Inc. announced it plans to raise $182 million in a secondary public offering of its common stock, pricing 6.4 million shares at $28.50 apiece.
Tracon Receives $10M in Development Deal With Japanese Drugmaker
San Diego-based Tracon Pharmaceuticals Inc. has received $10 million upfront after entering a global development and commercialization deal with Japanese drugmaker Santen Pharmaceutical Co. Ltd.
J. Craig Venter Part of Team Launching Human Longevity Inc.
San Diego super-scientist J. Craig Venter has launched a new company, Human Longevity Inc. that aims to prolong the human lifespan through genomics and cell therapy-based diagnostics.
Connect Appoints New CEO
Connect, a San Diego life sciences and technology nonprofit, has appointed veteran health care and investment banking executive Greg McKee as its new CEO.
Cardium Enters Strategic Collaboration, Will Change Name
Cardium Therapeutics Inc. has entered a strategic collaboration and funding arrangement with Shanxi Taxus Pharmaceuticals Co. Ltd. of China to support the worldwide clinical and commercial development of San Diego-based Cardium’s regenerative medicine therapeutics products.
Acadia Plans $150M Secondary Stock Offering
Acadia Pharmaceuticals Inc. announced it plans to raise $150 million in a secondary public offering of its common stock, though it didn’t indicate how it might use the proceeds.
MEI Pharma’s Leukemia Drug Receives Orphan Status From FDA
MEI Pharma Inc.’s investigational drug Pracinostat for treating acute myeloid leukemia has been granted orphan drug designation by the U.S. Food and Drug Administration, the company announced.
Abide to Receive $50M Upfront in Collaboration with Celgene Corp.
Privately held Abide Therapeutics Inc. has partnered with biotech titan Celgene Corp. to develop new drugs in inflammation and immunology, receiving $50 million upfront in the deal.
Isis' Stock Drops After Company Reports Q4 Results
Isis Pharmaceuticals Inc.’s stock dropped nearly 10 percent following the announcement of its fourth quarter earnings, despite more than doubling its revenue for the quarter ended Dec. 31, 2013. The company’s net loss increased significantly, however.
Abide Receiving $50M Upfront in Collaboration With Celgene Corp.
Privately held Abide Therapeutics Inc. has partnered with biotech titan Celgene Corp. to develop new drugs in inflammation and immunology, receiving $50 million upfront in the deal.
Isis' Stock Is Down Following Report of Q4 Results
Isis Pharmaceuticals Inc.’s stock dropped 10 percent following the announcement of its fourth quarter earnings, despite more than doubling its revenue for the quarter ended Dec. 31, 2013.
Employers and Insurers Welcome ACA Implementation Delay
INSURANCE: Mandate Extended Until 2016 for Medium-Size Businesses
The recent decision by the Obama administration to delay some requirements of the Affordable Care Act is giving local employers more time to comply with rules that will require them to provide affordable health insurance to employees.
-
prev
- next
